BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 2858991)

  • 1. Vecuronium infusion dose requirements during fentanyl and halothane anesthesia in humans.
    Swen J; Gencarelli PJ; Koot HW
    Anesth Analg; 1985 Apr; 64(4):411-4. PubMed ID: 2858991
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vecuronium infusion requirements in pediatric patients during fentanyl-N2O-O2 anesthesia.
    Meretoja OA
    Anesth Analg; 1989 Jan; 68(1):20-4. PubMed ID: 2562909
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Atracurium infusion requirements in children during halothane, isoflurane, and narcotic anesthesia.
    Brandom BW; Cook DR; Woelfel SK; Rudd GD; Fehr B; Lineberry CG
    Anesth Analg; 1985 May; 64(5):471-6. PubMed ID: 3158254
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Circulatory effects of vecuronium as well as pancuronium under different conditions of anesthesia].
    Markschies-Hornung A; Woroszylski F; Schulte-Sasse U; Tarnow J
    Anasth Intensivther Notfallmed; 1985 Apr; 20(2):57-61. PubMed ID: 2861759
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vecuronium and porcine malignant hyperthermia.
    Buzello W; Williams CH; Chandra P; Watkins ML; Dozier SE
    Anesth Analg; 1985 May; 64(5):515-9. PubMed ID: 2859814
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of atracurium, vecuronium and pancuronium on heart rate and arterial pressure in normal individuals.
    Lavery GG; Mirakhur RK; Clarke RS; Gibson FM
    Eur J Anaesthesiol; 1986 Nov; 3(6):459-67. PubMed ID: 2885185
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vecuronium infusion requirements in children during halothane-narcotic-nitrous oxide, isoflurane-narcotic-nitrous oxide, and narcotic-nitrous oxide anesthesia.
    Woelfel SK; Dong ML; Brandom BW; Sarner JB; Cook DR
    Anesth Analg; 1991 Jul; 73(1):33-8. PubMed ID: 1677545
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Muscle relaxation with an infusion of vecuronium.
    Mirakhur RK; Ferres CJ
    Eur J Anaesthesiol; 1984 Dec; 1(4):353-9. PubMed ID: 6152617
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evolution of vecuronium requirements for stable mechanical effect: comparison with or without previous succinylcholine administration.
    d'Hollander A; Agoston S; Barvais L; Massaut J; Baurain M
    Anesth Analg; 1985 Mar; 64(3):319-22. PubMed ID: 2858168
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dose requirements of vecuronium, pancuronium, and atracurium during orthotopic liver transplantation.
    O'Kelly B; Jayais P; Veroli P; Lhuissier C; Ecoffey C
    Anesth Analg; 1991 Dec; 73(6):794-8. PubMed ID: 1683184
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics and pharmacodynamics of vecuronium administered by bolus and infusion during halothane or balanced anesthesia.
    Shanks CA; Avram MJ; Fragen RJ; O'Hara DA
    Clin Pharmacol Ther; 1987 Oct; 42(4):459-64. PubMed ID: 2889555
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Continuous infusions of atracurium and vecuronium, compared with intermittent boluses of pancuronium: dose requirements and reversal.
    Beattie WS; Buckley DN; Forrest JB
    Can J Anaesth; 1992 Nov; 39(9):925-31. PubMed ID: 1360337
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetic-pharmacodynamic relationship of rocuronium under stable nitrous oxide-fentanyl or nitrous oxide-sevoflurane anesthesia in children.
    Woloszczuk-Gebicka B; Wyska E; Grabowski T; Swierczewska A; Sawicka R
    Paediatr Anaesth; 2006 Jul; 16(7):761-8. PubMed ID: 16879519
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Vecuronium in infants and children: clinical and neuromuscular effects].
    Motsch J; Hutschenreuter K; Ismaily AJ; von Blohn K
    Anaesthesist; 1985 Aug; 34(8):382-7. PubMed ID: 2864880
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Administration of vecuronium, atracurium and pancuronium in divided doses: effect on onset and duration of action.
    Brady MM; Mirakhur RK; Clarke RS
    Eur J Anaesthesiol; 1988 Jul; 5(4):243-9. PubMed ID: 2904367
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuromuscular effects of vecuronium (ORG NC45) in infants and children during N2O, halothane anesthesia.
    Fisher DM; Miller RD
    Anesthesiology; 1983 Jun; 58(6):519-23. PubMed ID: 6134483
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dose-response relation and time course of action of pipecuronium bromide in humans anesthetized with nitrous oxide and isoflurane, halothane, or droperidol and fentanyl.
    Wierda JM; Richardson FJ; Agoston S
    Anesth Analg; 1989 Mar; 68(3):208-13. PubMed ID: 2537588
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Propofol potentiates the neuromuscular blocking effects of vecuronium in man].
    Watanabe K; Ohmi Y; Adachi H; Satoh T
    Masui; 2000 Jan; 49(1):2-6. PubMed ID: 10689835
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mivacurium infusion requirements following vecuronium: different response between adults and children.
    Denman W; Goudsouzian N
    Can J Anaesth; 1995 Jul; 42(7):597-602. PubMed ID: 7553995
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative pharmacokinetics and dynamics of vecuronium and pancuronium in anesthetized patients.
    Sohn YJ; Bencini AF; Scaf AH; Kersten UW; Agoston S
    Anesth Analg; 1986 Mar; 65(3):233-9. PubMed ID: 2869721
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.